|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Current assets: | ||||||||||||
| Cash | ||||||||||||
| Deferred offering costs associated with proposed public offering | ||||||||||||
| Prepaid expenses | ||||||||||||
| Total current assets | ||||||||||||
| Cash held in Trust Account | ||||||||||||
| Total assets | ||||||||||||
| LIABILITIES, ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION, AND SHAREHOLDERS' DEFICIT | ||||||||||||
| Current liabilities: | ||||||||||||
| Accounts payable | ||||||||||||
| Related Party | ||||||||||||
| Nonrelated Party | ||||||||||||
| Due to related party | ||||||||||||
| Related Party | ||||||||||||
| Total due to related party | ||||||||||||
| Extension promissory notes | ||||||||||||
| Working capital promissory notes | ||||||||||||
| Deferred legal fees | ||||||||||||
| Accrued expenses | ||||||||||||
| Total current liabilities | ||||||||||||
| Deferred underwriting fees payable | ||||||||||||
| Deferred legal fees | ||||||||||||
| Total liabilities | ||||||||||||
| Shareholders' deficit | ||||||||||||
| Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued or outstanding at June 30, 2026 and December 31, 2025 | ||||||||||||
| Ordinary shares | ||||||||||||
| Class A | ||||||||||||
| Class B | ||||||||||||
| Additional paid-in capital | ||||||||||||
| Accumulated deficit | ||||||||||||
| Total shareholders' deficit | ||||||||||||
| Total Liabilities, Ordinary Shares Subject to Possible Redemption, and Shareholders' Deficit |
Loading...
